EA200500152A1 - Вторичные аминоанилиновые пиперидины в качестве антагонистов мкг1 и их применение - Google Patents
Вторичные аминоанилиновые пиперидины в качестве антагонистов мкг1 и их применениеInfo
- Publication number
- EA200500152A1 EA200500152A1 EA200500152A EA200500152A EA200500152A1 EA 200500152 A1 EA200500152 A1 EA 200500152A1 EA 200500152 A EA200500152 A EA 200500152A EA 200500152 A EA200500152 A EA 200500152A EA 200500152 A1 EA200500152 A1 EA 200500152A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- subject
- compound
- present
- treating
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Данное изобретение направлено на соединения, которые являются селективными антагонистами рецепторов-1 меланинконцентрирующего гормона (МКГ-1). В изобретении предлагается фармацевтическая композиция, включающая терапевтически эффективное количество соединения изобретения и фармацевтически приемлемый носитель. В данном изобретении предлагается фармацевтическая композиция, полученная объединением терапевтически эффективного количества соединения данного изобретения и фармацевтически приемлемого носителя. В данном изобретении дополнительно предлагается способ получения фармацевтической композиции, включающий объединение терапевтически эффективного количества соединений изобретения и фармацевтически приемлемого носителя. В данном изобретении также предлагается способ снижения массы тела у субъекта, который включает введение субъекту количества соединения изобретения, эффективного для снижения массы тела у субъекта. В данном изобретении дополнительно предлагается способ лечения субъекта, страдающего депрессией и/или тревожностью, который включает введение субъекту количества соединения изобретения, эффективного для лечения у субъекта депрессии и/или тревожности. В данном изобретении дополнительно предлагается способ лечения субъекта, страдающего нарушением мочеиспускания.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18914502A | 2002-07-03 | 2002-07-03 | |
PCT/US2003/021391 WO2004005257A1 (en) | 2002-07-03 | 2003-07-03 | Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200500152A1 true EA200500152A1 (ru) | 2005-06-30 |
EA008826B1 EA008826B1 (ru) | 2007-08-31 |
Family
ID=30114020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200500152A EA008826B1 (ru) | 2002-07-03 | 2003-07-03 | Вторичные аминоанилиновые пиперидины в качестве антагонистов мкг1 и их применение |
Country Status (19)
Country | Link |
---|---|
US (1) | US7473698B2 (ru) |
EP (1) | EP1556351A4 (ru) |
JP (1) | JP2005532399A (ru) |
KR (1) | KR20050034710A (ru) |
CN (1) | CN1319945C (ru) |
AU (1) | AU2003259098A1 (ru) |
BR (1) | BR0312257A (ru) |
CA (1) | CA2485379A1 (ru) |
EA (1) | EA008826B1 (ru) |
HK (1) | HK1080471A1 (ru) |
IL (1) | IL165730A0 (ru) |
IS (1) | IS7560A (ru) |
MX (1) | MXPA04012103A (ru) |
NO (1) | NO20050113L (ru) |
NZ (1) | NZ536329A (ru) |
PL (1) | PL373621A1 (ru) |
UA (1) | UA77536C2 (ru) |
WO (1) | WO2004005257A1 (ru) |
ZA (1) | ZA200409425B (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7105544B2 (en) | 2001-07-05 | 2006-09-12 | Synaptic Pharmaceutical Corporation | Substituted alkyl amido piperidines |
US7199135B2 (en) | 2001-07-05 | 2007-04-03 | H. Lundbeck A/S | Substituted alkyl amido piperidines |
US20050154022A1 (en) * | 2004-01-14 | 2005-07-14 | H. Lundbeck A/S | 4-aryl piperidines |
US20050154020A1 (en) * | 2004-01-14 | 2005-07-14 | Synaptic Pharmaceutical Corporation | 4-Aryl piperidines |
WO2006015279A1 (en) * | 2004-07-28 | 2006-02-09 | Neurogen Corporation | Heterocyclic diamine compounds as ligands of the melanin concentrating hormone receptor useful for the treatment of obesity, diabetes, eating and sexual disorders |
US7329656B2 (en) | 2004-10-08 | 2008-02-12 | H. Lundbeck A/S | Arylthiobenzylpiperidine derivatives |
US20060079683A1 (en) * | 2004-10-08 | 2006-04-13 | Marzabadi Mohammad R | Arylthiobenzylpiperidine derivatives |
US7446204B2 (en) | 2004-10-08 | 2008-11-04 | H. Lundbeck A/S | Amino substituted aryloxybenzylpiperidine derivatives |
US9452980B2 (en) * | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
AU2017234042B2 (en) | 2016-03-17 | 2020-11-19 | F. Hoffmann-La Roche Ag | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of TAAR |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2058061T3 (es) | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
FR2744448B1 (fr) | 1996-02-02 | 1998-04-24 | Pf Medicament | Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
TW548271B (en) * | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
ES2157148B1 (es) * | 1998-11-18 | 2002-03-01 | Faes Fabrica Espanola De Produ | Nuevas piperidinas 4-sustituidas. |
US6326381B1 (en) | 1998-12-17 | 2001-12-04 | American Home Products Corporation | Arylpiperidine and aryl-1,2,5,6-tetrahydropyidine amide derivates |
US20030082623A1 (en) * | 1998-12-31 | 2003-05-01 | Beth Borowsky | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
JP2004504303A (ja) * | 2000-07-05 | 2004-02-12 | シナプティック・ファーマスーティカル・コーポレーション | 選択的メラニン凝集ホルモン−1(mch1)受容体アンタゴニストおよびその使用 |
AU7320701A (en) * | 2000-07-05 | 2002-01-14 | Synaptic Pharmaceutical Corporation | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
US6953801B2 (en) | 2001-05-22 | 2005-10-11 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
EP1411942A4 (en) | 2001-07-05 | 2005-01-26 | Synaptic Pharma Corp | SUBSTITUTED ANILINE PIPERIDINES AS SELECTIVE MCH ANTAGONISTS |
-
2003
- 2003-03-07 UA UA20041210489A patent/UA77536C2/uk unknown
- 2003-07-03 JP JP2004520047A patent/JP2005532399A/ja not_active Withdrawn
- 2003-07-03 WO PCT/US2003/021391 patent/WO2004005257A1/en active Application Filing
- 2003-07-03 PL PL03373621A patent/PL373621A1/xx not_active Application Discontinuation
- 2003-07-03 CA CA002485379A patent/CA2485379A1/en not_active Abandoned
- 2003-07-03 IL IL16573003A patent/IL165730A0/xx unknown
- 2003-07-03 KR KR1020057000078A patent/KR20050034710A/ko not_active Application Discontinuation
- 2003-07-03 AU AU2003259098A patent/AU2003259098A1/en not_active Abandoned
- 2003-07-03 MX MXPA04012103A patent/MXPA04012103A/es active IP Right Grant
- 2003-07-03 EP EP03763374A patent/EP1556351A4/en not_active Withdrawn
- 2003-07-03 CN CNB038157667A patent/CN1319945C/zh not_active Expired - Fee Related
- 2003-07-03 US US10/518,675 patent/US7473698B2/en not_active Expired - Fee Related
- 2003-07-03 BR BR0312257-3A patent/BR0312257A/pt not_active IP Right Cessation
- 2003-07-03 NZ NZ536329A patent/NZ536329A/en unknown
- 2003-07-03 EA EA200500152A patent/EA008826B1/ru not_active IP Right Cessation
-
2004
- 2004-11-23 ZA ZA200409425A patent/ZA200409425B/en unknown
- 2004-11-26 IS IS7560A patent/IS7560A/is unknown
-
2005
- 2005-01-10 NO NO20050113A patent/NO20050113L/no not_active Application Discontinuation
-
2006
- 2006-01-09 HK HK06100334A patent/HK1080471A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2005532399A (ja) | 2005-10-27 |
CN1665786A (zh) | 2005-09-07 |
NZ536329A (en) | 2007-06-29 |
BR0312257A (pt) | 2005-04-12 |
MXPA04012103A (es) | 2005-04-19 |
PL373621A1 (en) | 2005-09-05 |
EP1556351A4 (en) | 2007-07-25 |
WO2004005257A1 (en) | 2004-01-15 |
EP1556351A1 (en) | 2005-07-27 |
US20050245743A1 (en) | 2005-11-03 |
IS7560A (is) | 2004-11-26 |
IL165730A0 (en) | 2006-01-15 |
US7473698B2 (en) | 2009-01-06 |
UA77536C2 (en) | 2006-12-15 |
KR20050034710A (ko) | 2005-04-14 |
CN1319945C (zh) | 2007-06-06 |
HK1080471A1 (en) | 2006-04-28 |
CA2485379A1 (en) | 2004-01-15 |
NO20050113L (no) | 2005-01-10 |
AU2003259098A1 (en) | 2004-01-23 |
EA008826B1 (ru) | 2007-08-31 |
ZA200409425B (en) | 2006-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050145L (no) | Spirocykliske piperidiner som MCH1-antagonister og anvendelser derav | |
EA200400146A1 (ru) | Замещённые анилиновые пиперидины в качестве селективных антагонистов mch | |
EA200501122A1 (ru) | Замещенные алкиламидопиперидины | |
EA200600190A1 (ru) | Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона | |
EA200100136A1 (ru) | Предотвращение образования слизистого секрета в дыхательных путях посредством введения антагонистов рецепторов эпидермального фактора роста (egf-r) | |
ATE306477T1 (de) | Selektive npy (y5) antagonisten | |
ECSP045391A (es) | Derivados de triazol como antagonistas de receptor de taquicinina | |
EA200600188A1 (ru) | Производные пиримидин-2,4-диона и их применение в качестве антагонистов рецепторов гонадолиберина | |
SE0100567D0 (sv) | Compounds | |
WO2002060392A3 (en) | Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | |
EA200500172A1 (ru) | Азабициклопроизводные в качестве антагонистов мускариновых рецепторов | |
EA200200194A1 (ru) | Антагонисты хемокинного рецептора и способы их применения | |
EA200500152A1 (ru) | Вторичные аминоанилиновые пиперидины в качестве антагонистов мкг1 и их применение | |
DE60215313D1 (de) | Indolderivate und deren verwendung als gnrh antagonisten | |
EA200601315A1 (ru) | 4-арилпиперидины | |
EA200501594A1 (ru) | Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора | |
ATE384066T1 (de) | Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren | |
EA200300850A1 (ru) | Применение антагонистов рецептора gal3 при лечении депрессии и/или тревоги и соединения, полезные в таких способах | |
WO2002022113A3 (en) | Retinoic acid receptor antagonists as promoters of angiogenesis | |
WO2004034967A3 (en) | 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety | |
BR0210869A (pt) | Composto, composição farmacêutica, processo de preparar uma composição farmacêutica, métodos de tratar um indivìduo que sofre de um distúrbio, de depressão e de ansiedade, obesidade, bexiga hiperativa e um distúrbio em um indivìduo, de reduzir a massa corporal de um indivìduo e de aliviar incontinência de urgência urinária e os sintomas de um distúrbio em um indivìduo | |
EA200301315A1 (ru) | Новые соединения и композиции в качестве ингибиторов катепсиса | |
EA200300770A1 (ru) | Антагонисты рецепторов возбуждающей аминокислоты |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): BY RU |